Anti-HSV1 ICP0抗体[5H7] (ab6513)

发表研究结果有使用 ab6513?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab6513 被引用在 7 文献中.

  • Jurak I  et al. Herpes simplex virus is equipped with RNA- and protein-based mechanisms to repress expression of ATRX, an effector of intrinsic immunity. J Virol 86:10093-102 (2012). PubMed: 22787211
  • Berger KL  et al. Hepatitis C Virus Stimulates the Phosphatidylinositol 4-Kinase III Alpha-Dependent Phosphatidylinositol 4-Phosphate Production That Is Essential for Its Replication. J Virol 85:8870-83 (2011). PubMed: 21697487
  • Fukuyo Y  et al. The Herpes Simplex Virus Immediate-Early Ubiquitin Ligase ICP0 Induces Degradation of the ICP0 Repressor Protein E2FBP1. J Virol 85:3356-66 (2011). PubMed: 21248039
  • Alazard-Dany N  et al. Definition of herpes simplex virus type 1 helper activities for adeno-associated virus early replication events. PLoS Pathog 5:e1000340 (2009). WB . PubMed: 19282980
  • Duffy C  et al. VP22 of herpes simplex virus 1 promotes protein synthesis at late times in infection and accumulation of a subset of viral mRNAs at early times in infection. J Virol 83:1009-17 (2009). WB . PubMed: 18987147
  • McMahon R & Walsh D Efficient quiescent infection of normal human diploid fibroblasts with wild-type herpes simplex virus type 1. J Virol 82:10218-30 (2008). WB . PubMed: 18701599
  • Geoffroy MC  et al. Herpes simplex virus type 1 ICP0 protein mediates activation of adeno-associated virus type 2 rep gene expression from a latent integrated form. J Virol 78:10977-86 (2004). WB, ICC/IF . PubMed: 15452218

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"